NewLink Genetics Corporation (NASDAQ: NLNK) today announced the company initiated a project to develop new treatment options for the Zika ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments Momentum Movers

NewLink (NLNK), Intrexon (XON), OraSure (OSUR) Highlighted on Zika - MizuhoFebruary 2, 2016 11:55 AM NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika VirusFebruary 2, 2016 7:00 AM